A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma

NCT03579082 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: Decitabine

Sponsor

Mingzhi Zhang